Clinical trials: sponsored by University Hospital, Limoges
Non Small Cell Lung Cancer
Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung Cancer
This 2 arms study will compare the efficacy and safety of treatment with sequential erlotinib plus docetaxel therapy versus docetaxel alone as second line treatment in patients with recurrent non-small cell lung cancer.
- Trial name
- TARSEQ (NCT01350817)
- Testing
- Erlotinib + docetaxel, Docetaxel
- Where
- 30 sites in France
- Volunteers
- 156 people
- Sponsor
- University Hospital, Limoges
Actinic Keratoses
Actinic Keratoses Treatment With Metvix® in Combination With Light
The main objective of this study is to compare efficacy and safety of Metvix® natural daylight photodynamic therapy with those of Metvix® conventional photodynamic therapy in subjects with mild actinic keratoses (intra-individual…
- Trial name
- NCT02373371
- Testing
- Metvix®, Photodynamic Therapy Blue light, Photodynamic Therapy Daylight
- Where
- France
- Volunteers
- 26 people
- Sponsor
- University Hospital, Limoges